Literature DB >> 14962737

Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system.

Julia Jungnickel1, Kathleen Gransalke, Marco Timmer, Claudia Grothe.   

Abstract

Fibroblast growth factor receptor (FGFR) signaling is crucial for neural development and regeneration. Here we investigated the L5 spinal ganglion and the sciatic nerve of intact Fgfr3-deficient mice after nerve injury. Quantification of sensory neurons in the L5 spinal ganglion revealed no significant differences between wild-type and Fgfr3-deficient mice. Seven days after nerve lesion, the normally occurring neuron loss in wild-type mice was not found in Fgfr3-deficient animals, suggesting that FGFR3 signaling is involved in the cell death process. Morphometric analysis of the sciatic nerve showed similar numbers of myelinated axons, but the axonal and myelin diameter was significantly smaller in Fgfr3-deficient mice compared to the wild types. Evaluation of regenerating myelinated axons of the sciatic nerve revealed no differences between both mouse strains 7 days after crush injury. Our results suggest that FGFR3 signaling seems to be involved in processes of damage-induced neuron death and axonal development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962737     DOI: 10.1016/j.mcn.2003.09.014

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  8 in total

Review 1.  Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responses.

Authors:  Robert J Romanelli; Teresa L Wood
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

2.  A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.

Authors:  Wen Wee Ma; Hao Xie; Gerald Fetterly; Laura Pitzonka; Amy Whitworth; Charles LeVea; John Wilton; Krystin Mantione; Sarah Schihl; Grace K Dy; Patrick Boland; Renuka Iyer; Wei Tan; William Brady; Robert M Straubinger; Alex A Adjei
Journal:  Am J Clin Oncol       Date:  2019-02       Impact factor: 2.339

3.  Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion.

Authors:  Marco Timmer; Konstantin Cesnulevicius; Christian Winkler; Julia Kolb; Esther Lipokatic-Takacs; Julia Jungnickel; Claudia Grothe
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 4.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 5.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

6.  The neurochemistry of peripheral nerve regeneration.

Authors:  Andreea Benga; Fatih Zor; Ahmet Korkmaz; Bogdan Marinescu; Vijay Gorantla
Journal:  Indian J Plast Surg       Date:  2017 Jan-Apr

7.  Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study.

Authors:  Elanagan Nagarajan; Seung Ah Kang; Carmen Holmes; Raghav Govindarajan
Journal:  BMC Neurol       Date:  2021-02-15       Impact factor: 2.474

8.  The transcriptional landscape of dorsal root ganglia after sciatic nerve transection.

Authors:  Shiying Li; Chengbin Xue; Ying Yuan; Ruirui Zhang; Yaxian Wang; Yongjun Wang; Bin Yu; Jie Liu; Fei Ding; Yuming Yang; Xiaosong Gu
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.